Headlands Technologies LLC Takes Position in Maximus, Inc. (NYSE:MMS)

Headlands Technologies LLC acquired a new stake in Maximus, Inc. (NYSE:MMS) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 3,885 shares of the health services provider’s stock, valued at approximately $290,000.

Other hedge funds have also added to or reduced their stakes in the company. UMB Bank n.a. increased its holdings in shares of Maximus by 79.8% in the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock worth $27,000 after acquiring an additional 158 shares in the last quarter. Eastern Bank acquired a new stake in Maximus during the 4th quarter worth approximately $29,000. V Square Quantitative Management LLC raised its holdings in Maximus by 65.9% during the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider’s stock worth $34,000 after buying an additional 180 shares during the period. R Squared Ltd bought a new position in Maximus in the fourth quarter valued at approximately $54,000. Finally, IFP Advisors Inc boosted its holdings in shares of Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider’s stock valued at $59,000 after buying an additional 302 shares during the period. Institutional investors and hedge funds own 97.21% of the company’s stock.

Analysts Set New Price Targets

MMS has been the topic of several research reports. Raymond James raised shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective on the stock in a research report on Thursday, January 2nd. StockNews.com lowered Maximus from a “buy” rating to a “hold” rating in a report on Friday, February 14th.

Maximus Price Performance

Shares of MMS opened at $68.61 on Friday. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $93.97. The stock has a market capitalization of $3.88 billion, a P/E ratio of 14.76 and a beta of 0.71. The company has a 50 day moving average of $69.16 and a 200-day moving average of $77.28.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. As a group, equities research analysts forecast that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Saturday, February 15th were given a dividend of $0.30 per share. The ex-dividend date was Friday, February 14th. This represents a $1.20 annualized dividend and a yield of 1.75%. Maximus’s dividend payout ratio (DPR) is presently 25.81%.

Insider Buying and Selling at Maximus

In other news, Director Jan Madsen sold 2,439 shares of the stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the sale, the director now owns 18,097 shares of the company’s stock, valued at approximately $1,225,347.87. This represents a 11.88 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction dated Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the transaction, the insider now directly owns 2,512 shares of the company’s stock, valued at approximately $171,167.68. This trade represents a 85.23 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company’s stock.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.